메뉴 건너뛰기




Volumn 31, Issue 43, 2013, Pages 4975-4983

First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers

(28)  Spring, Michele a   Murphy, Jittawadee a   Nielsen, Robin a   Dowler, Megan a   Bennett, Jason W a   Zarling, Stasya a   Williams, Jack a   de la Vega, Patricia a   Ware, Lisa a   Komisar, Jack a   Polhemus, Mark a   Richie, Thomas L b   Epstein, Judy b   Tamminga, Cindy b   Chuang, Ilin b   Richie, Nancy a   O'Neil, Michael a   Heppner, D Gray a   Healer, Julie c   O'Neill, Matthew c   more..


Author keywords

First in human; Genetically attenuated parasite; Malaria; Plasmodium falciparum

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR;

EID: 84885182610     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.08.007     Document Type: Article
Times cited : (106)

References (42)
  • 1
    • 84856679687 scopus 로고    scopus 로고
    • Global malaria mortality between 1980 and 2010: a systematic analysis
    • Murray C.J.L., Rosenfeld L.C., Lim S.S., Andrews K.G., Foreman K.J., Haring D., et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012, 379(9814):413-431.
    • (2012) Lancet , vol.379 , Issue.9814 , pp. 413-431
    • Murray, C.J.L.1    Rosenfeld, L.C.2    Lim, S.S.3    Andrews, K.G.4    Foreman, K.J.5    Haring, D.6
  • 2
    • 84887212463 scopus 로고    scopus 로고
    • Conserved protective mechanisms in radiation and genetically attenuated uis3(-) and uis4(-) Plasmodium sporozoites
    • Kumar K.A., Baxter P., Tarun A.S., Kappe S.H., Nussenzweig V. Conserved protective mechanisms in radiation and genetically attenuated uis3(-) and uis4(-) Plasmodium sporozoites. PLoS One 2009, 4(2):e4480.
    • (2009) PLoS One , vol.4 , Issue.2
    • Kumar, K.A.1    Baxter, P.2    Tarun, A.S.3    Kappe, S.H.4    Nussenzweig, V.5
  • 3
    • 84862684539 scopus 로고    scopus 로고
    • Malaria vaccine development: persistent challenges
    • April
    • Vaughan A.M., Kappe S.H. Malaria vaccine development: persistent challenges. Curr Opin Immunol 2012, April.
    • (2012) Curr Opin Immunol
    • Vaughan, A.M.1    Kappe, S.H.2
  • 4
    • 84871037616 scopus 로고    scopus 로고
    • A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
    • November
    • A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants. N Engl J Med 2012, November.
    • (2012) N Engl J Med
  • 5
    • 84885172175 scopus 로고    scopus 로고
    • Malaria.
    • Malaria. http://www.who.int/immunization/topics/malaria/en/.
  • 6
    • 84885187330 scopus 로고    scopus 로고
    • FDA: Complete List of Vaccines Licensed for Immunization and Distribution in the US.
    • FDA: Complete List of Vaccines Licensed for Immunization and Distribution in the US.
  • 7
    • 0014202885 scopus 로고
    • Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei
    • October (5111)
    • Nussenzweig R.S., Vanderberg J., Most H., Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 1967, 216(October (5111)):160-162.
    • (1967) Nature , vol.216 , pp. 160-162
    • Nussenzweig, R.S.1    Vanderberg, J.2    Most, H.3    Orton, C.4
  • 8
    • 0015699215 scopus 로고
    • Immunization of man against sporozite-induced falciparum malaria
    • September (3)
    • Clyde D.F., Most H., McCarthy V.C., Vanderberg J.P. Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci 1973, 266(September (3)):169-177.
    • (1973) Am J Med Sci , vol.266 , pp. 169-177
    • Clyde, D.F.1    Most, H.2    McCarthy, V.C.3    Vanderberg, J.P.4
  • 9
    • 0015736375 scopus 로고
    • Specificity of protection of man immunized against sporozoite-induced falciparum malaria
    • December (6)
    • Clyde D.F., McCarthy V.C., Miller R.M., Hornick R.B. Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am J Med Sci 1973, 266(December (6)):398-403.
    • (1973) Am J Med Sci , vol.266 , pp. 398-403
    • Clyde, D.F.1    McCarthy, V.C.2    Miller, R.M.3    Hornick, R.B.4
  • 10
    • 0016740645 scopus 로고
    • Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites
    • May (3)
    • Clyde D.F. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg 1975, 24(May (3)):397-401.
    • (1975) Am J Trop Med Hyg , vol.24 , pp. 397-401
    • Clyde, D.F.1
  • 11
    • 0016370621 scopus 로고
    • Letter: sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum
    • Rieckmann K.H., Carson P.E., Beaudoin R.L., Cassells J.S., Sell K.W. Letter: sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg 1974, 68(3):258-259.
    • (1974) Trans R Soc Trop Med Hyg , vol.68 , Issue.3 , pp. 258-259
    • Rieckmann, K.H.1    Carson, P.E.2    Beaudoin, R.L.3    Cassells, J.S.4    Sell, K.W.5
  • 12
    • 0018593563 scopus 로고
    • Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria
    • Rieckmann K.H., Beaudoin R.L., Cassells J.S., Sell K.W. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull World Health Organ 1979, 57(Suppl 1):261-265.
    • (1979) Bull World Health Organ , vol.57 , Issue.SUPPL 1 , pp. 261-265
    • Rieckmann, K.H.1    Beaudoin, R.L.2    Cassells, J.S.3    Sell, K.W.4
  • 13
    • 0025613796 scopus 로고
    • Human immunization with attenuated sporozoites
    • Rieckmann K.H. Human immunization with attenuated sporozoites. Bull World Health Organ 1990, 68(Suppl):13-16.
    • (1990) Bull World Health Organ , vol.68 , Issue.SUPPL , pp. 13-16
    • Rieckmann, K.H.1
  • 14
    • 12744278200 scopus 로고    scopus 로고
    • Genetically modified Plasmodium parasites as a protective experimental malaria vaccine
    • January (7022)
    • Mueller A.K., Labaied M., Kappe S.H., Matuschewski K. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 2005, 433(January (7022)):164-167.
    • (2005) Nature , vol.433 , pp. 164-167
    • Mueller, A.K.1    Labaied, M.2    Kappe, S.H.3    Matuschewski, K.4
  • 15
    • 14544281079 scopus 로고    scopus 로고
    • Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface
    • February (8)
    • Mueller A.K., Camargo N., Kaiser K., Andorfer C., Frevert U., Matuschewski K., et al. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci U S A 2005, 102(February (8)):3022-3027.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 3022-3027
    • Mueller, A.K.1    Camargo, N.2    Kaiser, K.3    Andorfer, C.4    Frevert, U.5    Matuschewski, K.6
  • 16
    • 24744448659 scopus 로고    scopus 로고
    • Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells
    • van Dijk M.R. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci 2005, 102(34):12194-12199.
    • (2005) Proc Natl Acad Sci , vol.102 , Issue.34 , pp. 12194-12199
    • van Dijk, M.R.1
  • 17
    • 34547621806 scopus 로고    scopus 로고
    • Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection
    • August (8)
    • Labaied M., Harupa A., Dumpit R.F., Coppens I., Mikolajczak S.A., Kappe S.H. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect Immun 2007, 75(August (8)):3758-3768.
    • (2007) Infect Immun , vol.75 , pp. 3758-3768
    • Labaied, M.1    Harupa, A.2    Dumpit, R.F.3    Coppens, I.4    Mikolajczak, S.A.5    Kappe, S.H.6
  • 19
    • 79958717556 scopus 로고    scopus 로고
    • Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites
    • June (6)
    • Butler N.S., Schmidt N.W., Vaughan A.M., Aly A.S., Kappe S.H., Harty J.T. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microb 2011, 9(June (6)):451-462.
    • (2011) Cell Host Microb , vol.9 , pp. 451-462
    • Butler, N.S.1    Schmidt, N.W.2    Vaughan, A.M.3    Aly, A.S.4    Kappe, S.H.5    Harty, J.T.6
  • 21
    • 34250827428 scopus 로고    scopus 로고
    • Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum - infected mosquitoes: an update
    • Epstein Judith E., Rao S., Williams F., Freilich D., Luke T., Sedegah M., et al. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum - infected mosquitoes: an update. J Infect Dis 2007, 196(1):145-154.
    • (2007) J Infect Dis , vol.196 , Issue.1 , pp. 145-154
    • Epstein Judith, E.1    Rao, S.2    Williams, F.3    Freilich, D.4    Luke, T.5    Sedegah, M.6
  • 22
    • 33747184555 scopus 로고    scopus 로고
    • Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hypoerendemic region of western Kenya
    • Stoute J.A., Heppner D.G., Mason C.J., Siangla J., Oppollo M.O., Kester K.E., et al. Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hypoerendemic region of western Kenya. Am J of Trop Med Hyg 2006, 75:166-170.
    • (2006) Am J of Trop Med Hyg , vol.75 , pp. 166-170
    • Stoute, J.A.1    Heppner, D.G.2    Mason, C.J.3    Siangla, J.4    Oppollo, M.O.5    Kester, K.E.6
  • 24
    • 70449356589 scopus 로고    scopus 로고
    • Multiple functions of human T cells generated by experimental malaria challenge
    • November (11)
    • Todryk S.M., Walther M., Bejon P., Hutchings C., Thompson F.M., Urban B.C., et al. Multiple functions of human T cells generated by experimental malaria challenge. Eur J Immunol 2009, 39(November (11)):3042-3051.
    • (2009) Eur J Immunol , vol.39 , pp. 3042-3051
    • Todryk, S.M.1    Walther, M.2    Bejon, P.3    Hutchings, C.4    Thompson, F.M.5    Urban, B.C.6
  • 25
    • 27144489392 scopus 로고    scopus 로고
    • Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria
    • November (9)
    • Keating S.M., Bejon P., Berthoud T., Vuola J.M., Todryk S., Webster D.P., et al. Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria. J Immunol 2005, 175(November (9)):5675-5680.
    • (2005) J Immunol , vol.175 , pp. 5675-5680
    • Keating, S.M.1    Bejon, P.2    Berthoud, T.3    Vuola, J.M.4    Todryk, S.5    Webster, D.P.6
  • 26
    • 0029097457 scopus 로고
    • T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens
    • October (8)
    • Krzych U., Lyon J.A., Jareed T., Schneider I., Hollingdale M.R., Gordon D.M., et al. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. J Immunol 1995, 155(October (8)):4072-4077.
    • (1995) J Immunol , vol.155 , pp. 4072-4077
    • Krzych, U.1    Lyon, J.A.2    Jareed, T.3    Schneider, I.4    Hollingdale, M.R.5    Gordon, D.M.6
  • 27
    • 10744227629 scopus 로고    scopus 로고
    • Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma
    • December (12)
    • Sun P., Schwenk R., White K., Stoute J.A., Cohen J., Ballou W.R., et al. Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma. J Immunol 2003, 171(December (12)):6961-6967.
    • (2003) J Immunol , vol.171 , pp. 6961-6967
    • Sun, P.1    Schwenk, R.2    White, K.3    Stoute, J.A.4    Cohen, J.5    Ballou, W.R.6
  • 28
    • 84873564071 scopus 로고    scopus 로고
    • Immune mechanisms in malaria: new insights in vaccine development
    • February (2)
    • Riley E.M., Stewart V.A. Immune mechanisms in malaria: new insights in vaccine development. Nat Med 2013, 19(February (2)):168-178.
    • (2013) Nat Med , vol.19 , pp. 168-178
    • Riley, E.M.1    Stewart, V.A.2
  • 29
    • 84862219278 scopus 로고    scopus 로고
    • Advances and challenges in malaria vaccine development
    • Wang R., Smith J.D., Kappe S.H. Advances and challenges in malaria vaccine development. Expert Rev Mol Med 2009, 11:e39.
    • (2009) Expert Rev Mol Med , vol.11
    • Wang, R.1    Smith, J.D.2    Kappe, S.H.3
  • 30
    • 0037090258 scopus 로고    scopus 로고
    • Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites
    • April (8)
    • Hoffman S.L., Goh L.M., Luke T.C., Schneider I., Le T.P., Doolan D.L., et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002, 185(April (8)):1155-1164.
    • (2002) J Infect Dis , vol.185 , pp. 1155-1164
    • Hoffman, S.L.1    Goh, L.M.2    Luke, T.C.3    Schneider, I.4    Le, T.P.5    Doolan, D.L.6
  • 32
    • 79956358442 scopus 로고    scopus 로고
    • Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study
    • May (9779)
    • Roestenberg M., Teirlinck A.C., McCall M.B., Teelen K., Makamdop K.N., Wiersma J., et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 2011, 377(May (9779)):1770-1776.
    • (2011) Lancet , vol.377 , pp. 1770-1776
    • Roestenberg, M.1    Teirlinck, A.C.2    McCall, M.B.3    Teelen, K.4    Makamdop, K.N.5    Wiersma, J.6
  • 33
    • 80055087402 scopus 로고    scopus 로고
    • Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity
    • September (334)
    • Epstein J.E., Tewari K., Lyke K.E., Sim B.K., Billingsley P.F., Laurens M.B., et al. Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science 2011, (September (334)):475-480.
    • (2011) Science , pp. 475-480
    • Epstein, J.E.1    Tewari, K.2    Lyke, K.E.3    Sim, B.K.4    Billingsley, P.F.5    Laurens, M.B.6
  • 34
    • 84860360435 scopus 로고    scopus 로고
    • Whole parasite vaccination approaches for prevention of malaria infection
    • May (5)
    • Butler N.S., Vaughan A.M., Harty J.T., Kappe S.H. Whole parasite vaccination approaches for prevention of malaria infection. Trends Immunol 2012, 33(May (5)):247-254.
    • (2012) Trends Immunol , vol.33 , pp. 247-254
    • Butler, N.S.1    Vaughan, A.M.2    Harty, J.T.3    Kappe, S.H.4
  • 35
    • 34548454445 scopus 로고    scopus 로고
    • Preerythrocytic malaria vaccine development
    • October (5)
    • Mikolajczak S.A., Aly A.S., Kappe S.H. Preerythrocytic malaria vaccine development. Curr Opin Infect Dis 2007, 20(October (5)):461-466.
    • (2007) Curr Opin Infect Dis , vol.20 , pp. 461-466
    • Mikolajczak, S.A.1    Aly, A.S.2    Kappe, S.H.3
  • 36
    • 34250827428 scopus 로고    scopus 로고
    • Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update
    • July (1)
    • Epstein J.E., Rao S., Williams F., Freilich D., Luke T., Sedegah M., et al. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. J Infect Dis 2007, 196(July (1)):145-154.
    • (2007) J Infect Dis , vol.196 , pp. 145-154
    • Epstein, J.E.1    Rao, S.2    Williams, F.3    Freilich, D.4    Luke, T.5    Sedegah, M.6
  • 37
  • 38
    • 84870846671 scopus 로고    scopus 로고
    • Plasmodium berghei Deltap52&p36 parasites develop independent of a parasitophorous vacuole membrane in Huh-7 liver cells
    • Ploemen I.H., Croes H.J., van Gemert G.J., Wijers-Rouw M., Hermsen C.C., Sauerwein R.W. Plasmodium berghei Deltap52&p36 parasites develop independent of a parasitophorous vacuole membrane in Huh-7 liver cells. PLoS One 2012, 7(12):e50772.
    • (2012) PLoS One , vol.7 , Issue.12
    • Ploemen, I.H.1    Croes, H.J.2    van Gemert, G.J.3    Wijers-Rouw, M.4    Hermsen, C.C.5    Sauerwein, R.W.6
  • 39
    • 33747184555 scopus 로고    scopus 로고
    • Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hyperendemic region of western Kenya
    • July (1)
    • Stoute J.A., Heppner D.G., Mason C.J., Siangla J., Opollo M.O., Kester K.E., et al. Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hyperendemic region of western Kenya. Am J Trop Med Hyg 2006, 75(July (1)):166-170.
    • (2006) Am J Trop Med Hyg , vol.75 , pp. 166-170
    • Stoute, J.A.1    Heppner, D.G.2    Mason, C.J.3    Siangla, J.4    Opollo, M.O.5    Kester, K.E.6
  • 40
    • 34547614313 scopus 로고    scopus 로고
    • Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells
    • August (4)
    • Jobe O., Lumsden J., Mueller A.K., Williams J., Silva-Rivera H., Kappe S.H., et al. Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. J Infect Dis 2007, 196(August (4)):599-607.
    • (2007) J Infect Dis , vol.196 , pp. 599-607
    • Jobe, O.1    Lumsden, J.2    Mueller, A.K.3    Williams, J.4    Silva-Rivera, H.5    Kappe, S.H.6
  • 41
    • 79960149284 scopus 로고    scopus 로고
    • Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-alpha producing effector and central memory CD4 T cells
    • Lumsden J.M., Schwenk R.J., Rein L.E., Moris P., Janssens M., Ofori-Anyinam O., et al. Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-alpha producing effector and central memory CD4 T cells. PLoS One 2011, 6(7):e20775.
    • (2011) PLoS One , vol.6 , Issue.7
    • Lumsden, J.M.1    Schwenk, R.J.2    Rein, L.E.3    Moris, P.4    Janssens, M.5    Ofori-Anyinam, O.6
  • 42
    • 0042123673 scopus 로고    scopus 로고
    • Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells
    • August (4)
    • Berenzon D., Schwenk R.J., Letellier L., Guebre-Xabier M., Williams J., Krzych U. Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells. J Immunol 2003, 171(August (4)):2024-2034.
    • (2003) J Immunol , vol.171 , pp. 2024-2034
    • Berenzon, D.1    Schwenk, R.J.2    Letellier, L.3    Guebre-Xabier, M.4    Williams, J.5    Krzych, U.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.